Our findings reveal a previously unrecognized role for CYP19A1 in regulating chemoresistance through modulation of mitochondrial function and complex I activity, providing new insights into the complex interplay between hormone signaling, mitochondrial metabolism, and drug resistance in CRC. Here, CYP19A1 is linked to colorectal carcinoma.